NCT01106482

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

A Phase IV, Open-label, Multi-center Follow-up Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 126 (actual)
• Sponsor: Novartis Vaccines · Industry
• Sex: All
• Age: 4 Years – 14 Years
• Healthy volunteers: Accepted

Summary

This study will evaluate the durability of antibody responses in children and adolescents after primary immunization with TBE vaccine

Conditions

• Tick Borne Encephalitis (TBE)

Interventions

Type	Name	Description
OTHER	Serology blood draw	Blood draw only, no vaccine

Timeline

• Start date: 2009-05-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2010-04-20
• Last updated: 2011-12-08

Locations

10 sites across 1 country: Germany